Effect of Docosahexaenoic Acid Supplementation on neonatal outcomes of pereterm infants

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20221120056556N2

Enrollment

384

Registered

2023-01-28

Start date

2022-12-22

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutrition of premature babies / Growth of premature babies / Prognosis of premature babies.

Interventions

Intervention group:Premature babies are divided into intervention and placebo groups using a random number table. So that the people who met the conditions to enter the study will be treated by pre-co

Eligibility

Sex/Gender

All

Age

1 Days to 30 Days

Inclusion criteria

Inclusion criteria: Preterm infants with gestational age less than 34 weeks. Birth weight less than 2000 gr.

Exclusion criteria

Exclusion criteria: Infants need to major surgery Infants with major congenital anomalies Exclusively formula fed infants Discharge to home on less than 14th day of life Infants of mother whit special treatment diet

Design outcomes

Primary

Measure	Time frame
Determining the effect of Docosahexaenoic acid on the growth indices of premature infants. Timepoint: During the study, the growth indices will be checked daily to measure weight and weekly to measure height and head circumference, and they will be checked until the time the baby is admitted to the hospital. Method of measurement: A scale will be used to measure weight and a meter will be used to measure height.	—

Measure

Time frame

Determining the effect of Docosahexaenoic acid on the growth indices of premature infants. Timepoint: During the study, the growth indices will be checked daily to measure weight and weekly to measure height and head circumference, and they will be checked until the time the baby is admitted to the hospital. Method of measurement: A scale will be used to measure weight and a meter will be used to measure height.

—

Secondary

Measure	Time frame
Investigating the effect of Docosahexaenoic acid on the incidence of intraventricular hemorrhage in preterm infants. Timepoint: During the whole time of the baby's stay in the hospital. Method of measurement: With brain ultrasonography.;Investigating the effect of Docosahexaenoic acid acid acids on the incidence of neonatal sepsis in preterm infants. Timepoint: During the whole time of the baby's stay in the hospital. Method of measurement: Clinical finding and blood culture examination.;Investigating the effect of Docosahexaenoic acids on the incidence of neonatal necrotizing enteroculitis in preterm infants. Timepoint: During the whole time of the baby's stay in the hospital. Method of measurement: clinical and radiological findings.;Investigating the effect of Docosahexaenoic acids on the incidence of retinopathy of prematurity in preterm infants. Timepoint: During the whole time of the baby's stay in the hospital. Method of measurement: Based on the retinal exam by ophthalmologist.	—

Measure

Time frame

Investigating the effect of Docosahexaenoic acid on the incidence of intraventricular hemorrhage in preterm infants. Timepoint: During the whole time of the baby's stay in the hospital. Method of measurement: With brain ultrasonography.;Investigating the effect of Docosahexaenoic acid acid acids on the incidence of neonatal sepsis in preterm infants. Timepoint: During the whole time of the baby's stay in the hospital. Method of measurement: Clinical finding and blood culture examination.;Investigating the effect of Docosahexaenoic acids on the incidence of neonatal necrotizing enteroculitis in preterm infants. Timepoint: During the whole time of the baby's stay in the hospital. Method of measurement: clinical and radiological findings.;Investigating the effect of Docosahexaenoic acids on the incidence of retinopathy of prematurity in preterm infants. Timepoint: During the whole time of the baby's stay in the hospital. Method of measurement: Based on the retinal exam by ophthalmologist.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMinoo Fallahi

Shahid Beheshti University of Medical Sciences

minoofallahi@yahoo.com+98 21 2243 9770

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026